MiNK Therapeutics
@MiNK_iNKT
MiNK is a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf, $INKT cell therapies to treat cancer and other immune-mediated diseases
@MiNK_iNKT hasn’t posted
When they do, their posts will show up here.